How Mass Spectrometry Verifies a Peptide's Identity

What does a mass spectrometer actually measure on a peptide?

A mass spectrometer does not weigh a peptide directly. It converts the molecule into gas-phase ions, then measures the mass-to-charge ratio of those ions. The raw output is a spectrum of mass-to-charge values and their intensities; the peptide's molecular mass is then derived from those values together with the charge each ion carries. This distinction matters when reading a Certificate of Analysis, because the single "observed mass" figure printed on a report is an interpretation of an underlying spectrum, not a direct reading from a balance.

Mass spectrometry became the central identification technique in peptide and protein analysis because it is both sensitive and specific about molecular composition. Aebersold and Mann, writing in Nature in 2003 (source 1), described mass-spectrometry-based analysis as an indispensable tool for molecular and cellular biology, and the identification workflows that review describes are the same ones behind the identity line on a modern peptide COA.

Mass-to-charge ratio (m/z)

What the instrument measures: an ion's mass divided by the number of charges it carries.

Charge state

How many charges a given ion carries. The same peptide commonly appears at several charge states, producing several related peaks.

Monoisotopic mass

The mass calculated using the lightest, most abundant isotope of each element. Conventional for peptides, where individual isotope peaks are resolved.

Average mass

The mass calculated using the natural isotope-weighted average of each element. Used where isotopes are not resolved, and slightly higher than the monoisotopic value.

Dalton (Da)

The unit mass is reported in. A difference of a few daltons between observed and theoretical mass is chemically meaningful, not rounding.

How is the observed mass compared to the theoretical mass?

The theoretical mass is calculated from the claimed sequence: the known masses of each amino acid residue are summed, with an allowance for the water lost at each peptide bond and for any stated modification such as an amide at the C-terminus. That calculated figure is what the measured value is judged against. A COA should print both numbers side by side, and they should agree.

Agreement is judged against a stated tolerance, expressed either in daltons or in parts per million. Expressing it in parts per million lets one acceptance criterion apply across peptides of very different sizes, since it scales the allowed deviation to the mass being measured. The practical point for a researcher reviewing a report is that a tolerance should be stated at all: an observed mass presented without the theoretical value or a tolerance cannot be checked, only accepted on trust.

How do ESI and MALDI differ when verifying a research peptide?

Two ionization methods dominate peptide work, and both were established in the late 1980s. Electrospray ionization was described by Fenn and colleagues in Science in 1989 (source 3). Spraying the peptide from solution produced what those authors described as coherent sequences of peaks whose component ions are multiply charged, with adjacent peaks differing by a single charge unit. That paper reported measurements on proteins with molecular weights reaching 130,000 daltons and noted no apparent upper mass limit. Laser desorption approaches trace to Karas and Hillenkamp's 1988 report in Analytical Chemistry (source 4), which demonstrated laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons.

Neither method is inherently more correct for verifying a research peptide. What matters on a report is that the method is named, so the reported mass can be interpreted in context — a multiply charged ESI spectrum and a singly charged MALDI spectrum are read differently.

How does tandem mass spectrometry read the amino acid sequence?

An intact mass confirms composition, not order. Two peptides assembled from the same residues in a different sequence have the same formula and therefore the same mass. Tandem mass spectrometry addresses this by isolating the peptide ion and fragmenting it, then measuring the masses of the fragments.

Steen and Mann's 2004 review in Nature Reviews Molecular Cell Biology (source 2) set out the nomenclature this depends on: fragments retaining the N-terminus are labelled a, b and c, while those retaining the C-terminus are labelled x, y and z, with b and y ions predominating under the low-energy collision-induced dissociation used in routine work. Because consecutive fragments in a series differ by exactly one residue, the mass gaps between adjacent peaks spell out the sequence. That review also notes the limit of the approach: leucine and isoleucine are identical in mass and are not distinguished this way.

Why does a matching mass not prove the material is pure?

This is the most consequential misreading of a peptide COA. A confirmed mass establishes that a molecule of the expected composition is present in the sample. It does not establish how much of the sample is that molecule, and it does not describe what else is present. A vial containing the correct peptide alongside a substantial fraction of truncated sequences, deletion sequences or residual solvent can still return a clean, matching molecular ion.

Purity is a separate measurement, and on a peptide COA it is normally an HPLC percentage backed by a chromatogram — see how HPLC is used to test peptide purity for how that figure is produced and read. Identity and purity answer different questions, and a complete report carries both. Every Steadfast Research Group batch is documented with a batch-matched COA precisely so that the identity data and the purity data can be checked against the vial in hand rather than against a generic product claim.

What can make an observed mass differ from the theoretical value?

A mismatch is informative rather than merely disqualifying, because the size of the gap often points at its cause. Chemical modifications acquired during synthesis, purification or storage shift mass by characteristic amounts, and adducts formed with alkali metal ions during ionization add mass without altering the underlying molecule. Steen and Mann (source 2) describe how such modifications propagate through a fragment series, which is what allows a modified residue to be localised rather than merely detected.

One frequent source of confusion is not a mass discrepancy at all. Synthetic peptides are typically isolated as salts, and the counterion contributes to the weight of the powder without appearing in the measured peptide ion. A 2025 study in Pharmaceuticals (source 5) found trifluoroacetate reaching up to 35 percent of the total weight of peptide salts, measured 0.333 milligrams of trifluoroacetate per milligram of peptide salt for one angiotensin peptide, and reported that counterions associate with basic residues in roughly a one-to-one molar ratio. That mass is real, but it is a question of how much peptide the vial holds rather than whether the peptide is the right one — a distinction that carries directly into concentration calculations at reconstitution.

What should researchers check in the mass-spec section of a COA?

Reviewing the identity section of a report is a short, repeatable exercise. The theoretical mass should be printed, not just the observed one, so the comparison is visible. The ionization method should be named. The tolerance or acceptance criterion should be stated. The lot number on the report should match the vial label, so the spectrum belongs to the material actually in hand rather than to an earlier batch. Where a sequence claim matters, tandem data — not intact mass alone — is what supports it. A report that omits these elements has not been falsified, but it also cannot be independently checked — which is why a batch-matched certificate published alongside each product is more useful to a researcher than a generic document produced only on request.